TB's fatty acid vulnerability: TB15.3 keeps infection alive

Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis, survives in parts of the body rich in fats. Long-chain fatty acids (LCFA) are among the most common lipids Mtb encounters during infection. The bacterium has adapted to use LCFA as a preferred source of carbon and energy, but those same fatty acids can also act like potent antimicrobials, damaging the bacterium. This creates a challenge: Mtb needs to take up and break down LCFA to live, yet must prevent the toxic effects of those molecules. To understand how Mtb walks this tightrope, researchers led by Sabine Ehrt used genome-scale screening to map out which bacterial genes are required to resist LCFA toxicity. Their goal was to find the network of genes that together allow Mtb to exploit LCFA without being killed by them. The team discovered a set of genes that make up what they call the LCFA resistome, and they followed up on one striking member of that network: the universal stress protein TB15.3. By focusing on this protein, the researchers sought to connect individual gene function to the bacterium’s ability to survive in lipid-rich environments and during infection.

To identify the genes that protect Mtb from LCFA, the team applied transposon sequencing (TnSeq), a genetic screening technology that pinpoints which bacterial genes are necessary under specific conditions. The TnSeq screen revealed an LCFA resistome made up of 38 genes. This finding was surprising because the list included a diverse set of metabolic pathways, suggesting LCFA affect multiple parts of Mtb’s metabolism rather than producing a single type of damage. As a focused follow-up, the researchers studied the universal stress protein TB15.3 to understand its role in LCFA handling and infection. Their experiments showed that TB15.3 functions as a “metabolic break”: it slows LCFA uptake and catabolism, preventing harmful membrane hyperpolarization that would otherwise occur when LCFA are processed too quickly. Loss of this control was linked to loss of bacterial viability in the chronic phase of infection in mice and in an in vitro caseum model, demonstrating TB15.3’s importance for survival under host-like conditions.

These results highlight that resisting LCFA toxicity is a vital adaptation for Mtb in the host environment. Rather than a single defense, Mtb relies on many metabolic systems to balance the benefits and risks of using host lipids, and TB15.3 stands out as a key regulator of that balance. By acting as a brake on LCFA uptake and breakdown, TB15.3 helps Mtb avoid lethal changes to its membrane and maintain viability during long-term infection. The study positions the LCFA resistome—and TB15.3 in particular—as a promising target space for new therapies: drugs that disrupt these resistance mechanisms could make Mtb vulnerable to the very lipids it encounters in the host. Overall, this work suggests that interfering with how Mtb manages host fats could be a productive strategy to weaken the bacterium during the chronic stages of tuberculosis.